H.R. 4818

House

Treat and Reduce Obesity Act of 2023

Sponsor: Rep. Brad Wenstrup (R-OH)

In debate

The bill is being debated or has cleared committee and is moving toward a floor vote.

In brief

This bill expands Medicare coverage to include medications specifically approved for the treatment of obesity or for weight loss in individuals with overweight. It also authorizes the Department of Health and Human Services to expand intensive behavioral therapy services for obesity by allowing additional types of qualified providers to deliver these services. The legislation targets Medicare beneficiaries with obesity and would take effect upon enactment. It was introduced by Rep. Brad Wenstrup (R-OH) and remains under consideration in the 118th Congress.

Timeline

Every recorded action, oldest first.

July 19, 2024 · House
Introduced
This bill allows for Medicare Part D coverage of anti-obesity drugs and expands intensive behavioral therapy for obesity to more healthcare providers. It was the most-viewed bill for the week of July 19, 2026.
Next: Referred to the House Committee on Energy and Commerce.
Source
July 22, 2024 · House
Reported from committee
Expands Medicare Part D coverage to include FDA-approved weight-loss medications. The bill was reported from the House Committee on Ways and Means.
Next: Awaits a floor vote in the House.
Source
July 26, 2025 · House
Introduced
Expands Medicare coverage to include intensive behavioral therapy for obesity and weight-loss drugs. This bill has consistently been the most-viewed piece of legislation.
Next: Referred to the House Committee on Energy and Commerce.
Source
July 19, 2026 · House
Introduced
The most viewed bill as of July 19, 2026, it aims to reduce obesity by allowing Medicare Part D to cover weight loss drugs and improving access to intensive behavioral therapy.
Next: Referred to the House Committee on Energy and Commerce.
Source
July 19, 2026 · House
Debated
A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of obesity drugs and expanded access to therapy.
Next: Pending further action in the House.
Source
July 19, 2026 · House
Reported from committee
The bill expands Medicare coverage for obesity-related medications and behavioral therapy. It was the most-viewed bill for the week of July 19, 2026.
Next: Awaits potential floor consideration in the House.
Source
July 26, 2026 · House
Introduced
This bill expands Medicare coverage to include medications and additional behavioral therapy for the treatment of obesity. It is currently the most viewed bill for the week of July 26, 2026.
Next: Referred to House committees for consideration.
Source